High prevalence of factor V Leiden mutation in mothers of premature neonates

E Erhardt1, J Stankovics, D Molnár

  • 1Department of Paediatrics, University Medical School of Pécs, Hungary. erhardte@apacs.pote.hu

Biology of the Neonate
|September 6, 2000
PubMed

Insights

The Leiden mutation is more prevalent in mothers of premature infants (18%) than in those with growth-retarded neonates (7.2%). This finding suggests a potential link between the Leiden mutation and premature birth, warranting further investigation.

Area of Science:

  • Medical Genetics
  • Obstetrics and Gynecology
  • Neonatology

Background:

  • The Leiden mutation, a common genetic risk factor for thrombosis, is associated with adverse pregnancy outcomes.
  • Premature birth and intrauterine growth retardation are significant neonatal health concerns with multifactorial causes.

Purpose of the Study:

  • To investigate the prevalence of the Leiden mutation in mothers of premature infants and neonates with intrauterine growth retardation.
  • To compare these prevalences with that of the general Hungarian population.

Main Methods:

  • Genotyping for the Leiden mutation was performed on two groups of mothers: 50 mothers of premature infants and 56 mothers of intrauterine-growth-retarded neonates.
  • Prevalence data were compared statistically with a control group of healthy Hungarian subjects.

Main Results:

  • The prevalence of the Leiden mutation was 18% in mothers of premature infants.
  • The prevalence was 7.2% in mothers of growth-retarded neonates.
  • The prevalence in mothers of premature infants was significantly higher (p < 0.01) than in the healthy Hungarian population (6.3%).

Conclusions:

  • The study suggests a potential, previously unrecognized association between the Leiden mutation and premature birth.
  • Further research with larger cohorts is needed to confirm this relationship and elucidate its clinical significance.

Related Concept Videos

Probability Laws01:49

Probability Laws

Overview
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...